No abstract available
MeSH terms
-
Antibodies, Neutralizing / therapeutic use*
-
Antibodies, Viral / therapeutic use*
-
Antibody-Dependent Enhancement / drug effects
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Serotherapy
-
Complement Pathway, Alternative / drug effects
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / immunology
-
Coronavirus Infections / mortality
-
Coronavirus Infections / therapy*
-
Cytokine Release Syndrome / diagnosis
-
Cytokine Release Syndrome / immunology
-
Cytokine Release Syndrome / mortality
-
Cytokine Release Syndrome / therapy*
-
Disease Progression
-
Immunization, Passive / methods
-
Lymphopenia / diagnosis
-
Lymphopenia / immunology
-
Lymphopenia / mortality
-
Lymphopenia / therapy*
-
Pandemics
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / therapy*
-
Receptors, IgG / genetics
-
Receptors, IgG / immunology
-
SARS-CoV-2
-
Severity of Illness Index
-
Survival Analysis
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
Antiviral Agents
-
Receptors, IgG